148 related articles for article (PubMed ID: 9089329)
1. Synthesis and structure-activity relationships of carboxylated chalcones: a novel series of CysLT1 (LTD4) receptor antagonists.
Zwaagstra ME; Timmerman H; Tamura M; Tohma T; Wada Y; Onogi K; Zhang MQ
J Med Chem; 1997 Mar; 40(7):1075-89. PubMed ID: 9089329
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationships of carboxyflavones as structurally rigid CysLT1 (LTD4) receptor antagonists.
Zwaagstra ME; Timmerman H; van de Stolpe AC; de Kanter FJ; Tamura M; Wada Y; Zhang MQ
J Med Chem; 1998 Apr; 41(9):1428-38. PubMed ID: 9554876
[TBL] [Abstract][Full Text] [Related]
3. [Structure-activity relationship studies of chalcones as SRS-A receptor antagonists].
He KQ; Cheng GF; Xi FD; Guo ZR; Zhu XY
Yao Xue Xue Bao; 1996; 31(11):878-80. PubMed ID: 9863261
[TBL] [Abstract][Full Text] [Related]
4. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
5. In vitro pharmacologic profile of YM158, a new dual antagonist for LTD4 and TXA2 receptors.
Arakida Y; Suwa K; Ohga K; Yokota M; Miyata K; Yamada T; Honda K
J Pharmacol Exp Ther; 1998 Nov; 287(2):633-9. PubMed ID: 9808690
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of the novel, potent and selective peptide leukotriene antagonist (E)-2,2-diethyl-3'-[2-[2-(4-isopropyl)thiazolyl]ethenyl]succinanilic acid.
Yamada N; Yamada K; Takahashi K; Nakao E; Kadowaki S; Umezu K
Arzneimittelforschung; 1994 Jun; 44(6):749-53. PubMed ID: 8053974
[TBL] [Abstract][Full Text] [Related]
7. Development of a three-dimensional CysLT1 (LTD4) antagonist model with an incorporated amino acid residue from the receptor.
Zwaagstra ME; Schoenmakers SH; Nederkoorn PH; Gelens E; Timmerman H; Zhang MQ
J Med Chem; 1998 Apr; 41(9):1439-45. PubMed ID: 9554877
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore identification, synthesis, and biological evaluation of carboxylated chalcone derivatives as CysLT1 antagonists.
Dong X; Wang L; Huang X; Liu T; Wei E; Du L; Yang B; Hu Y
Bioorg Med Chem; 2010 Aug; 18(15):5519-27. PubMed ID: 20621485
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of 2-(4-biphenylyl)quinoline-4-carboxylate and carboxamide analogs. New human neurokinin-3 (hNK-3) receptor antagonists.
Saudi MN; Rostom SA; Fahmy HT; El Ashmawy IM
Arch Pharm (Weinheim); 2003 Jun; 336(3):165-74. PubMed ID: 12822182
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel series of styrylquinoline compounds as high-affinity leukotriene D4 receptor antagonists: synthetic and structure-activity studies leading to the discovery of (+-)-3-[[[3-[2-(7-chloro-2-quinolinyl)-(E)-ethenyl]phenyl][[3- (dimethylamino)-3-oxopropyl]thio]methyl]thio]propionic acid.
Zamboni R; Belley M; Champion E; Charette L; DeHaven R; Frenette R; Gauthier JY; Jones TR; Leger S; Masson P
J Med Chem; 1992 Oct; 35(21):3832-44. PubMed ID: 1331447
[TBL] [Abstract][Full Text] [Related]
11. 2,3-Dihydro-2-oxo-1H-benzimidazole-1-carboxamides with selective affinity for the 5-HT(4) receptor: synthesis and structure-affinity and structure-activity relationships of a new series of partial agonist and antagonist derivatives.
Tapia I; Alonso-Cires L; López-Tudanca PL; Mosquera R; Labeaga L; Innerárity A; Orjales A
J Med Chem; 1999 Jul; 42(15):2870-80. PubMed ID: 10425096
[TBL] [Abstract][Full Text] [Related]
12. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
Mikó T; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
J Med Chem; 2003 Apr; 46(8):1523-30. PubMed ID: 12672253
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of CR3465, a new leukotriene CysLT1 receptor antagonist with broad anti-inflammatory activity.
Ferrari F; Mennuni L; Caselli G; Zanelli T; Makovec F
Eur J Pharmacol; 2004 Nov; 504(3):223-33. PubMed ID: 15541426
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of leukotriene receptor antagonists.
Aharony D
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):S214-9. PubMed ID: 9620942
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene cysLT1 (LTD4) receptor antagonism of H1-antihistamines: an in vitro study.
Zhang MQ; Timmerman H
Inflamm Res; 1997 Mar; 46 Suppl 1():S93-4. PubMed ID: 9098782
[No Abstract] [Full Text] [Related]
17. Synthesis and structure-activity relationship studies of a series of 5-aryl-4,6-dithianonanedioic acids and related compounds: a novel class of leukotriene antagonists.
Perchonock CD; Uzinskas I; McCarthy ME; Erhard KF; Gleason JG; Wasserman MA; Muccitelli RM; DeVan JF; Tucker SS; Vickery LM
J Med Chem; 1986 Aug; 29(8):1442-52. PubMed ID: 3016267
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
[TBL] [Abstract][Full Text] [Related]
20. Optimization of the quinoline and substituted benzyl moieties of a series of phenyltetrazole leukotriene D4 receptor antagonists.
Sawyer JS; Baldwin RF; Rinkema LE; Roman CR; Fleisch JH
J Med Chem; 1992 Apr; 35(7):1200-9. PubMed ID: 1313877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
